Alterations in the blood brain barrier in ageing cerebral cortex in relationship to Alzheimer-type pathology: A study in the MRC-CFAS population neuropathology cohort

Neuroscience Letters

Volumn 505, Issue 1, 2011, Pages 25-30

  Viggars, Andrew P ^a   Wharton, Stephen B ^a   Simpson, Julie E ^a   Matthews, Fiona E ^b   Brayne, Carol ^c   Savva, George M ^d   Garwood, Claire ^a   Drew, David ^a   Shaw, Pamela J ^a   Ince, Paul G ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^d TRINITY COLLEGE DUBLIN   (Ireland)

Author keywords

Alzheimer's disease; Blood brain barrier; Brain ageing; Tight junction proteins

Indexed keywords

ALBUMIN; CLAUDIN 5; FIBRINOGEN; PROTEIN ZO1;

AGING; ALZHEIMER DISEASE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN; BRAIN CORTEX; COHORT ANALYSIS; DISEASE COURSE; DOWN REGULATION; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; LONGITUDINAL STUDY; NERVE CELL; NEUROPATHOLOGY; NONHUMAN; POPULATION RESEARCH; PRIORITY JOURNAL; TEMPORAL CORTEX;

AGED; AGED, 80 AND OVER; AGING; ALBUMINS; BLOOD-BRAIN BARRIER; CEREBRAL CORTEX; CLAUDINS; COHORT STUDIES; COLLAGEN TYPE IV; DISEASE PROGRESSION; DOWN-REGULATION; FEMALE; FIBRINOGEN; HUMANS; MALE; MEMBRANE PROTEINS; PHOSPHOPROTEINS; STATISTICS, NONPARAMETRIC;

EID: 82455162480     PISSN: 03043940     EISSN: 18727972     Source Type: Journal    
DOI: 10.1016/j.neulet.2011.09.049     Document Type: Article

References (35)

1. Abbott N., Ronnback L., Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat. Rev. Neurosci. 2006, 7:41-53.
2. Bauer H., Stelzhammer W., Fuchs R., Weiger T., Danninger C., Probst G., Krizbai I. Astrocytes and neurons express the tight junction-specific protein occludin in vitro. Exp. Cell Res. 1999, 250:434-438.
3. Braak H., Alafuzoff I., Arzberger T., Kretaschmar H., del Tredici K. Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry. Acta Neuropathol. 2006, 112:389-404.
4. Braak H., Braak E. Neuropathological stageing of Alzheimer-related changes. Acta Neuropathol. 1991, 82:239-259.
5. Brown W., Thore C. Cerebral microvascular pathology in ageing and neurodegeneration. Neuropathol. Appl. Neurobiol. 2011, 37:56-74.
6. Dallasta L., Pisarov L., Esplen J., Werley J., Moses A., Nelson J., Achim C. Blood-brain barrier tight junction disruption in human immunodeficiency virus-1 encephalitis. Am. J. Pathol. 1999, 155:1915-1927.
7. Farrall A., Wardlaw J. Blood-brain barrier: ageing and microvascular disease: systematic review and meta-analysis. Neurobiol. Aging 2009, 30:337-352.
8. Gonzalez-Velasquez F., Kotarek J., Moss M. Soluble aggregates of the amyloid-β protein selectively stimulate permeability in human brain microvascular endothelial monolayers. J. Neurochem. 2008, 107:466-477.
9. Hamm S., Dehouck B., Kraus J., Wolburg-Buchholz K., Wolburg H., Risau W., Cecchelli R., Engelhardt B., Dehouck M.-P. Astrocyte mediated modulation of blood-brain barrier permeability does not correlate with a loss of tight junction proteins from the cellular contacts. Cell Tissue Res. 2004, 315:157-166.
10. Howarth A., Hughes M., Stevenson B. Detection of the tight junction-associated protein ZO-1 in astrocytes and other nonepithelial cell types. J. Physiol. 1992, 262:C461-C469.
11. Kirk J., Plumb J., Mirakhur M., McQuaid S. Tight junctional abnormality in multiple sclerosis white matter affects all calibres of vessel and is associated with blood-brain barrier leakage and active demyelination. J. Pathol. 2003, 201:319-327.
12. Krizbai I., Bauer H., Bresgen N., Eckl P., Farkas A., Szatmari E., Traweger A., Wejksza K., Bauer H.-C. Effect of oxidative stress on the junctional proteins of culture cerebral endothelial cells. Cell. Mol. Neurobiol. 2005, 25:129-139.
13. Leech S., Kirk J., Plumb J., McQuaid S. Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol. Appl. Neurobiol. 2007, 33:86-98.
14. Loberg E., Karlsson B., Torvik A. Neuronal uptake of plasma proteins after transient cerebral ischemia/hypoxia. Immunohistochemical studies on experimental animals and human brains. APMIS 1993, 101:777-783.
15. Mann D., Eaves N., Marcyniuk B., Yates P. Quantitative changes in cerebral cortical microvasculature in ageing and dementia. Neurobiol. Aging 1986, 7:321-330.
16. Matthews F., Brayne C., Lowe J., McKeith I., Wharton S., Ince P. Epidemiological pathology of dementia: attributable-risks at death in the MRC cognitive function and ageing study. PLOS Med 2009, 6:e1000180. doi:1000110.1001371/journal.pmed.1000180.
17. Mirra S., Heyman A., McKeel D., Sumi S., Crain B., Brownlee L., Vogel F., Hughes J., Van Belle G., Berg L. The consortium to establish a registry for Alzheimer's disease (CERAD). Part II. Standardisation of the neuropathologic assessment of Alzheimer's disease. Neurology 1991, 41:479-486.
18. MRC-CFAS Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales. Lancet 2001, 357:169-175.
19. Nag S., Kapadia A., Stewart D. Review: molecular pathogenesis of blood-brain barrier breakdown in acute brain injury. Neuropathol. Appl. Neurobiol. 2011, 37:3-23.
20. Nunomura A., Castellani R., Zhu X., Moreira P., Perry G., Smith M. Involvement of oxidative stress in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2006, 65:631-641.
21. Nunomura A., Hofer T., Moreira P., Castellani R., Smith M., Perry G. RNA oxidation in Alzheimer disease and related neurodegenerative disorders. Acta Neuropathol 2009, 118:151-166.
22. Nunomura A., Perry G., Aliev G., Hirai K., Takeda A., Balraj E., Jones P., Ghanbari H., Wataya T., Shimohama S., Chiba S., Atwood C., Petersen R., Smith M. Oxidative damage is the earliest event in Alzheimer disease. J. Neuropathol. Exp. Neurol. 2001, 60:759-767.
23. Penes M., Li X., Nagy J. Expression of zonula occludens-1 (ZO-1) and the transcription factor ZO-1-associated nucleic acid-binding protein (ZONAB)-MsY3 in glial cells and co-localisation at oligodendrocyte and astrocyte gap junctions in mouse brain. Eur. J. Neurosci. 2005, 22:404-418.
24. Popescu B., Toescu E., Popescu L.M., Bajenaru O., Muresanu D., Schultzberg M., Bogdanovic N. Blood-brain barrier alterations in ageing and dementia. J. Neurol. Sci. 2009, 283:99-106.
25. Romanitan M., Popescu B., Winblad B., Bajenaru O., Bogdanovic N. Occludin is overexpressed in Alzheimer's disease and vascular dementia. J. Cell. Mol. Med. 2007, 11:569-579.
26. Sandoval K., Witt K. Blood-brain barrier tight junction permeability and ischemic stroke. Neurobiol. Dis. 2008, 32:200-219.
27. Simpson J., Ince P., Haynes L., Theaker R., Gelsthorpe C., Baxter L., Forster G., Lace G., Shaw P., Matthews F., Savva G., Brayne C., Wharton S. Population variation in oxidative stress and astrocyte DNA damage in relation to Alzheimer-type pathology in the ageing brain. Neuropathol. Appl. Neurobiol. 2010, 36:25-40.
28. Simpson J., Ince P., Lace G., Forster G., Shaw P., Matthews F., Savva G., Brayne C., Wharton S. Astrocyte phenotype in relation to Alzheimer-type pathology in the ageing brain. Neurobiol. Aging 2010, 31:578-590.
29. Simpson J., Wharton S., Cooper J., Gelsthorpe C., Baxter L., Forster G., Shaw P., Savva G., Matthews F., Brayne C., Ince P. Alterations of the blood-brain barrier in cerebral white matter lesions in the ageing brain. Neurosci. Lett. 2010, 486:246-251.
30. Simpson J.E., Fernando M., Clark L., Ince P., Matthews F., Forster G., O'Brien J., Barber R., Kalaria R., Brayne C., Shaw P., Lewis C., Wharton S. White matter lesions in an unselected cohort of the elderly: astrocytic, microglial and oligodendrocyte precursor cell responses. Neuropathol. Appl. Neurobiol. 2007, 33:410-419.
31. Starr J., Farrall A., Armitage P., McGurn B., Wardlaw J. Blood-brain barrier permeability in Alzheimer's disease: a case-control MRI study. Psychiatr. Res. Neuroimaging 2009, 171:232-241.
32. Ujiie M., Dickstein D., Carlow D., Jefferies W. Blood-brain barrier permeability precedes senile plaque formation in an Alzheimer disease model. Microcirculation 2003, 10:463-470.
33. Weiss N., Miller F., Cazaubon S., Couraud P.-O. The blood-brain barrier in brain homeostasis and neurological diseases. Biochim. Biophys. Acta 2009, 1788:842-857.
34. Zipser B., Johanson C., Gonzalez L., Berzin T., Tavares R., Hulette C., Vitek M., Hovanesian V., Stopa E. Microvascular injury and blood-brain barrier leakage in Alzheimer's disease. Neurobiol. Aging 2007, 28:977-986.
35. Zlokovic B. The blood-brain barrier in health and chronic neurodegenerative disorders. Neuron 2008, 57:178-201.